Cargando…
Prognostic value of CYFRA 21 − 1 and Ki67 in advanced NSCLC patients with wild-type EGFR
BACKGROUND: The prognostic value of cytokeratin 19 fragment (CYFRA 21 − 1) and Ki67 in advanced non-small cell lung cancer (NSCLC) patients with wild-type epidermal growth factor receptor (EGFR) remains to be explored. METHODS: In this study, 983 primary NSCLC patients from January 2016 to December...
Autores principales: | Li, Tao, Xie, Qi, Fang, Yang-Yang, Sun, Yi, Wang, Xiao Ming, Luo, Zhu, Yan, Gui-Ling, He, Jian-Bo, Zheng, Xiao-Qun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064697/ https://www.ncbi.nlm.nih.gov/pubmed/37004004 http://dx.doi.org/10.1186/s12885-023-10767-9 |
Ejemplares similares
-
CEA and CYFRA 21-1 as prognostic biomarker and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitors
por: Dall’Olio, Filippo G., et al.
Publicado: (2020) -
Effect of gefitinib on serum EGFR and CYFRA21-1 in patients with advanced non-small cell lung cancer
por: Ren, Hui, et al.
Publicado: (2019) -
The Potential Value of Ki-67 in Prognostic Classification in Early Low-Risk Endometrial Cancer
por: Jia, Mingzhu, et al.
Publicado: (2023) -
The associations among quantitative spectral CT parameters, Ki-67 expression levels and EGFR mutation status in NSCLC
por: Lin, Liaoyi, et al.
Publicado: (2020) -
Circulating Tumor DNA correlates with Lactate Dehydrogenase, CYFRA 21-1, and CRP levels in patients with advanced NSCLC
por: Buresova, Marcela, et al.
Publicado: (2023)